StockNews.com Begins Coverage on LightPath Technologies (NASDAQ:LPTH) – Defense World
Posted by admin on Jun 11th, 2022 
StockNews.com began coverage on shares of LightPath Technologies (NASDAQ:LPTH – Get Rating) in a research note issued to investors on Saturday. The brokerage set a “hold” rating on the technology company’s stock.
LPTH has been the topic of a number of other research reports. HC Wainwright restated a “buy” rating and set a $3.50 price target on shares of LightPath Technologies in a research note on Tuesday, May 17th. B. Riley raised their price target on LightPath Technologies from $3.30 to $3.70 in a research note on Friday, February 11th.
LPTH opened at $1.39 on Friday. LightPath Technologies has a one year low of $1.19 and a one year high of $2.87. The company has a market cap of $37.60 million, a P/E ratio of -7.32 and a beta of 1.33. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.47 and a current ratio of 2.51. The business’s 50-day simple moving average is $1.64 and its 200-day simple moving average is $2.03.
LightPath Technologies (NASDAQ:LPTH – Get Rating) last released its quarterly earnings data on Thursday, May 12th. The technology company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.01. LightPath Technologies had a negative return on equity of 15.63% and a negative net margin of 14.56%. The business had revenue of $8.31 million for the quarter, compared to the consensus estimate of $9.83 million. During the same quarter in the prior year, the business posted ($0.01) EPS. As a group, analysts predict that LightPath Technologies will post -0.1 earnings per share for the current fiscal year.
In other news, Director Darcie Peck purchased 22,500 shares of the company’s stock in a transaction that occurred on Tuesday, March 29th. The shares were purchased at an average price of $2.08 per share, for a total transaction of $46,800.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 11.50% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC acquired a new position in shares of LightPath Technologies in the first quarter valued at approximately $30,000. Virtu Financial LLC acquired a new position in shares of LightPath Technologies in the first quarter valued at approximately $36,000. Goldman Sachs Group Inc. acquired a new position in shares of LightPath Technologies in the fourth quarter valued at approximately $52,000. Susquehanna International Group LLP increased its holdings in shares of LightPath Technologies by 61.1% in the fourth quarter. Susquehanna International Group LLP now owns 21,667 shares of the technology company’s stock valued at $53,000 after purchasing an additional 8,216 shares during the period. Finally, LPL Financial LLC increased its holdings in shares of LightPath Technologies by 55.3% in the third quarter. LPL Financial LLC now owns 36,500 shares of the technology company’s stock valued at $78,000 after purchasing an additional 13,000 shares during the period. 42.71% of the stock is currently owned by institutional investors and hedge funds.
About LightPath Technologies (Get Rating)
LightPath Technologies, Inc designs, develops, manufactures, and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, and other optical components used to produce products that manipulate light. Its products are used in defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other industries.
Recommended Stories
Receive News & Ratings for LightPath Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LightPath Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.
Moleculin Biotech (NASDAQ:MBRX) Now Covered by Analysts at StockNews.com
Exact Sciences (NASDAQ:EXAS) Upgraded by StockNews.com to Hold